Skip to Content

Grand Rounds

Printer Friendly Version
Date / Location Speaker Affiliation Topic
January 24, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Timothy Thompson, PhD MD Anderson Cancer Center Novel Approaches to PARP Inhibitor Therapy for Prostate Cancer
January 31, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Michel Sadelain, MD, PhD Memorial Sloan-Kettering Cancer Center CAR Therapy: The CD19 Paradigm and Beyond
February 07, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Thomas J. Walsh, MD, PhD Weill Cornell Medicine of Cornell University, New York The Global Impact of Infectious Diseases Supportive Care in Patients with Cancer: Standing on the Shoulders of A Giant
February 14, 2017
AT&T Auditorium - Main Building - B2.4750
Aung Naing, MD; Timothy Yap, PhD MD Anderson Cancer Center Advances in Developmental Therapeutics Dr. Yap- PARP Inhibitors: Lessons Learnt and Unanswered Questions Dr. Naing- Update on Immunotherapy
February 21, 2017
B2.4750 AT & T Auditorium; 8:00-9:00 a.m.
Guillermo Garcia-Manero, MD MD Anderson Cancer Center Towards a Cure for Myelodysplastic Syndromes (What can MD Anderson do to help)
February 28, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Scott E. Woodman, MD, PhD MD Anderson Cancer Center Cancer Cell-Intrinsic Features of Response to Targeted and Immune Therapies in Melanoma
March 07, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Robert S. Benjamin, MD MD Anderson Cancer Center Chemotherapy for Soft-Tissue Sarcomas: Old and New Drugs
March 21, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Cliona M. Rooney, PhD Baylor College of Medicine Enhancing T-cell Immunotherapy for Cancer
March 28, 2017
B2.4750 AT&T Auditorium; 8:00-9:00 a.m.
John L. Marshall, MD Georgetown University Medical Center Finding Value in Colon Cancer
April 04, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
CANCELLED MD Anderson Cancer Center DUE TO AACR
April 11, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Jeffrey A. Engelman, MD, PhD Vice President and Global Head of Oncology, Novartis Institutes for Biomedical Research Targeted Therapies and Resistance: Where Are We Going?
April 18, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Tina Cascone, MD, PhD; Brittany K. Ragon, MD; Sangeetha M. Reddy, MD; Matthew J. Reilley, MD; Michael J. Wagner, MD MD Anderson Cancer Center CASCONE: Inhibition of nonsense-mediated mRNA decay to improve immunotherapy for non-small cell lung cancer. RAGON: Functional Proteomic profiling of Myelodysplastic syndromes. REDDY: TBA REILLEY: TBA WAGNER: Identifying new targets for angiosarcoma
April 25, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Lorraine J. Gudas, MD Weill Cornell Medical College of Cornell University Nuclear Receptor Selective Agonists for the Prevention and Treatment of Cancer and Diabetes
May 02, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Jeffrey Molldrem, MD MD Anderson Cancer Center A T Cell Receptor-like Antibody to the PR1 Myeloid Leukemia Antigen Effectively Targets Cancer Stem Cells
May 09, 2017
B2.4750 - AT&T Auditorium; 8:00-9:00 a.m.
Jennifer B. Goldstein, MD; Sangeeta Goswami, PhD; Jennifer L. McQuade MD Anderson Cancer Center Division of Cancer Medicine Advanced Scholars Presentation
May 16, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Lauren Byers, MD; Nageshwara Dasari, MBBS; Daniel Halperin, MD; James Yao, MD MD Anderson Cancer Center TBA
May 23, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Hematology/ Oncology Fellows 2017 ASCO Presentation MD Anderson Cancer Center TBA
May 30, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
CANCELLED MD Anderson Cancer Center DUE TO THE HOLIDAY
June 06, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
CANCELLED MD Anderson Cancer Center DUE TO 2017 ASCO